Hope Bruce T, Simmons Danielle E, Mitchell Tim B, Kreuter Justin D, Mattson Brandi J
Behavioural Neuroscience Branch, Intramural Research Program, The National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA.
Eur J Neurosci. 2006 Aug;24(3):867-75. doi: 10.1111/j.1460-9568.2006.04969.x.
Induction of the immediate early gene protein product Fos has been used extensively to assess neural activation in the striatum after repeated cocaine administration to rats in their home cages but rarely after repeated administration outside the home cage, which produces more robust locomotor sensitization. In the present study, we found cocaine-induced Fos expression in nucleus accumbens, but not caudate-putamen, was enhanced 1 and 6 months after repeated drug administration in locomotor activity chambers. Double-labelling of Fos protein and enkephalin mRNA indicated that Fos expression in nucleus accumbens was enhanced in enkephalin-positive, but not enkephalin-negative, medium spiny neurons. In contrast, cocaine-induced Fos expression was absent altogether in nucleus accumbens and unaltered in caudate-putamen 1 month after repeated cocaine administration in the home cage. As cocaine-induced locomotor activity was also enhanced 1 and 6 months after repeated cocaine administration in locomotor activity chambers, we wanted to confirm that neuronal activity in nucleus accumbens mediates cocaine-induced locomotor activity using our particular treatment regimen. Bilateral infusions of the GABA agonists baclofen and muscimol (1 microg/side) into nucleus accumbens of sensitized rats blocked cocaine-induced Fos expression and locomotor activity. Thus, while neuronal activity in both D1- and D2-type neurons in nucleus accumbens can mediate acute cocaine-induced locomotor activity, the enhanced activation of enkephalinergic D2-type neurons suggests that these latter neurons mediate the enhancement of cocaine-induced locomotor activity for up to 6 months after repeated drug administration outside the home cage.
即时早期基因蛋白产物Fos的诱导已被广泛用于评估在家笼中反复给大鼠注射可卡因后纹状体中的神经激活情况,但在家笼外反复给药后(这种给药方式会产生更强的运动敏化)却很少进行此类评估。在本研究中,我们发现,在运动活动箱中反复给药1个月和6个月后,可卡因诱导的伏隔核而非尾状核-壳核中的Fos表达增强。Fos蛋白和脑啡肽mRNA的双重标记表明,伏隔核中Fos表达在脑啡肽阳性而非脑啡肽阴性的中等棘状神经元中增强。相比之下,在家笼中反复注射可卡因1个月后,伏隔核中完全没有可卡因诱导的Fos表达,而尾状核-壳核中的Fos表达未改变。由于在运动活动箱中反复注射可卡因1个月和6个月后,可卡因诱导的运动活动也增强了,我们想用我们特定的治疗方案来证实伏隔核中的神经元活动介导了可卡因诱导的运动活动。向致敏大鼠的伏隔核双侧注射GABA激动剂巴氯芬和蝇蕈醇(1微克/侧)可阻断可卡因诱导的Fos表达和运动活动。因此,虽然伏隔核中D1型和D2型神经元的活动均可介导急性可卡因诱导的运动活动,但脑啡肽能D2型神经元的激活增强表明,在笼外反复给药后长达6个月的时间里,这些神经元介导了可卡因诱导的运动活动增强。